Holen Sie sich die Stockscreener-App
16.12
3.47%
-0.58
Immunovant Inc Aktie (IMVT) Neueste Nachrichten
Earnings visualization tools for Immunovant Inc.Market Activity Summary & Consistent Income Trade Recommendations - Newser
Is Immunovant Inc. trending in predictive chart modelsJuly 2025 Levels & Weekly Return Optimization Alerts - Newser
Immunovant reports promising remission data for Graves’ disease therapy By Investing.com - Investing.com Australia
What is Immunovant Inc.’s book value per shareJuly 2025 Update & Daily Volume Surge Trade Alerts - khodrobank.com
Batoclimab data in Graves’ could signal bigger Immunovant win - BioWorld MedTech
Immunovant’s Batoclimab: A Game-Changer in the Evolving Graves’ Disease Market - AInvest
IMVT Stock Up 11% on Upbeat Batoclimab Hyperthyroidism Study Results - TradingView
Momentum divergence signals in Immunovant Inc. chart2025 Buyback Activity & AI Enhanced Trading Alerts - Newser
Is Immunovant Inc. a strong growth stockMarket Volume Summary & Consistent Income Trade Recommendations - khodrobank.com
What machine learning models say about Immunovant Inc.2025 Market Trends & Verified Entry Point Detection - Newser
Immunovant stock rises as Oppenheimer reiterates Outperform on Graves’ data - Investing.com
Real time social sentiment graph for Immunovant Inc.Entry Point & Long-Term Safe Return Strategies - Newser
What institutional flow reveals about Immunovant Inc.Market Trend Report & AI Optimized Trading Strategy Guides - Newser
Combining price and volume data for Immunovant Inc.July 2025 Outlook & Reliable Intraday Trade Plans - Newser
Why Immunovant Stock Blasted Higher Today - AOL.com
Can momentum traders help lift Immunovant Inc.Portfolio Return Report & Verified Chart Pattern Trade Signals - Newser
Why Immunovant Stock Blasted Higher Today - The Motley Fool
Immunovant Reports 'Encouraging' Data on Graves' Disease Treatment; Shares Rise - MarketScreener
What to expect from Immunovant Inc. in the next 30 daysQuarterly Performance Summary & Fast Entry and Exit Trade Plans - Newser
Immunovant Data for Batoclimab Shows Potential for Treating Uncontrolled Graves' Disease - MarketScreener
Immunovant Announces Promising Graves’ Disease Study Results - TipRanks
Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients - The Manila Times
Immunovant reports promising remission data for Graves’ disease therapy - Investing.com
Immunovant Reports Promising Six-Month Off-Treatment Data for Batoclimab in Uncontrolled Graves' Disease Patients - Quiver Quantitative
Immunovant Announces Promising Six-Month Follow-Up Data for Batoclimab in Uncontrolled Graves’ Disease Patients, Potentially Disease-Modifying Therapy - Quiver Quantitative
80% of Patients Maintain Normal Thyroid Function: Immunovant's Breakthrough in Graves' Disease Treatment Study - Stock Titan
Using data tools to time your Immunovant Inc. exit2025 Big Picture & Low Risk Entry Point Tips - Newser
Visual analytics tools that track Immunovant Inc. performanceJuly 2025 Sentiment & Community Verified Trade Alerts - Newser
Intraday pattern recognizer results for Immunovant Inc.Market Activity Summary & Real-Time Stock Price Movement Reports - Newser
Using RSI to spot recovery in Immunovant Inc.M&A Rumor & Consistent Growth Stock Picks - Newser
Volume spikes in Immunovant Inc. stock – what they meanRisk Management & Advanced Technical Signal Analysis - Newser
How to use a screener to detect Immunovant Inc. breakoutsJuly 2025 Rallies & Stepwise Trade Signal Implementation - Newser
Applying Elliott Wave Theory to Immunovant Inc.July 2025 Update & Verified Momentum Watchlists - Newser
Immunovant Inc. stock volume spike explainedWeekly Gains Summary & Growth Oriented Trading Recommendations - Newser
Is now a turning point for Immunovant Inc.2025 Risk Factors & Free Fast Entry Momentum Trade Alerts - Newser
Is Immunovant Inc. stock entering bullish territoryQuarterly Earnings Report & Fast Exit/Entry Strategy Plans - Newser
Real time breakdown of Immunovant Inc. stock performanceCPI Data & Fast Gaining Stock Strategy Reports - Newser
What indicators show strength in Immunovant Inc.Quarterly Earnings Report & Weekly Watchlist for Hot Stocks - Newser
Using economic indicators to assess Immunovant Inc. potentialMarket Risk Report & Low Risk High Win Rate Stock Picks - Newser
Immunovant Inc. stock outlook for YEARJuly 2025 Review & Fast Gaining Stock Reports - Newser
Is Immunovant Inc. stock poised for growthMarket Movement Recap & Free Weekly Watchlist of Top Performers - Newser
Long term hold vs stop loss in Immunovant Inc.Layoff News & Expert Approved Momentum Trade Ideas - Newser
What’s next for Immunovant Inc. stockJuly 2025 Analyst Calls & Free High Return Stock Watch Alerts - khodrobank.com
Short interest data insights for Immunovant Inc.July 2025 Patterns & Fast Entry and Exit Trade Plans - Newser
Immunovant Inc. stock trend outlook and recovery pathPortfolio Value Summary & Low Volatility Stock Suggestions - Newser
Should you avoid Immunovant Inc. stock right nowJuly 2025 Update & Advanced Swing Trade Entry Alerts - khodrobank.com
Regression analysis insights on Immunovant Inc. performanceQuarterly Profit Review & Expert Approved Momentum Ideas - Newser
Published on: 2025-09-01 10:52:28 - Newser
Is Immunovant Inc. a play on infrastructure spendingTrend Reversal & Safe Entry Zone Tips - khodrobank.com
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):